Erlotinib Side Effects
View Community-reported Erlotinib side effects
Add Your Side Effect to the Community Database
Help Community - Describe Your Erlotinib Side Effect
Have You dealt with a Erlotinib side effect? Share your experience
Erlotinib Side Effects submitted to FDA
Total Erlotinib reports: 580.Erlotinib FDA safety alerts: No.
Reported deaths: 178 Reported hospitalizations: 405.
Take Erlotinib Side Effects Survey, Discuss Erlotinib with others
FDA Reported Erlotinib Side Effects: disease progression, asthenia, anaemia, dehydration, haemoglobin decreased, pulmonary embolism, nausea, diarrhoea, diarrhoea haemorrhagic, vomiting, malignant neoplasm progression,
More About Erlotinib.
If you have questions about Erlotinib, you can ask a Health Expert or Ask Patient Community about Erlotinib.
< Previous Showing 101-150 of 580 Next >
Erlotinib Side Effects Report #5538344-2Health Professional from UNITED STATES reported ERLOTINIB problem on Nov 21, 2007. Male patient, 40 years of age, weighting 264.6 lb, was diagnosed with glioblastoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: thrombocytopenia. ERLOTINIB dosage: 150 MG, QD, ORAL. During the same period patient was treated with RAPAMUNE, DEXAMETHASONE, LEVETIRACETAM, RANITIDINE. Patient recovered.
Erlotinib Side Effects Report #5544125-6
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Nov 21, 2007. Male patient, 75 years of age, weighting 160.9 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: dehydration, oesophagitis. ERLOTINIB dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5545516-X
Physician from BELGIUM reported ERLOTINIB problem on Dec 03, 2007. Female patient, 66 years of age, was diagnosed with ovarian cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: dysphagia, gastritis. ERLOTINIB dosage: (150 MG, QD), ORAL. During the same period patient was treated with XANAX, TRAZOLAN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5549853-4
ERLOTINIB problem was reported by a Physician from UNITED STATES on Dec 06, 2007. Male patient, weighting 203.9 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: computerised tomogram abnormal, cough, dyspnoea, haemoptysis, hypoxia, pleural effusion. ERLOTINIB dosage: 150MG ORALLY QD. During the same period patient was treated with DASATIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5562710-2
Physician from UNITED STATES reported ERLOTINIB problem on Dec 11, 2007. Female patient, weighting 140.2 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: anaemia, diarrhoea, enterocolitis infectious, gastroenteritis, lower gastrointestinal haemorrhage. ERLOTINIB dosage: 150MG ORALLY QD. During the same period patient was treated with DASATINIB, ETODOLAC, NAPROSYN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5562834-X
ERLOTINIB problem was reported by a Physician from UNITED STATES on Dec 12, 2007. Male patient, weighting 140.2 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: aggression, cardio-respiratory arrest, disorientation, myocardial infarction. ERLOTINIB dosage: 150MG ORALLY QD. During the same period patient was treated with DASATINIB. Patient died on 12/06/2007.
Erlotinib Side Effects Report #5563256-8
Health Professional from reported ERLOTINIB problem on Nov 26, 2007. Male patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. ERLOTINIB dosage: 150 MG, QD, ORAL. Patient died.
Erlotinib Side Effects Report #5565819-2
ERLOTINIB problem was reported by a Physician from UNITED STATES on Nov 29, 2007. Male patient, 76 years of age, weighting 166.0 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, TOPROL, LIPITOR, NIASPAN, NITROSTAT, ASPIRIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5567366-0
Health Professional from SPAIN reported ERLOTINIB problem on Nov 30, 2007. Female patient, 58 years of age, was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia. ERLOTINIB dosage: (150 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PEMETREXED, DEXAMETHASONE, FOLIC ACID, VITAMIN B12. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5567652-4
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Nov 30, 2007. Female patient, 47 years of age, weighting 168.0 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: atelectasis, haematocrit decreased, haemoglobin decreased, haemoptysis, red blood cell count increased, tobacco abuse. ERLOTINIB dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, LIDOCAINE, CODEINE SUL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5567675-5
Health Professional from UNITED STATES reported ERLOTINIB problem on Nov 26, 2007. Female patient, 30 years of age, was diagnosed with anaplastic astrocytoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: blood culture positive, catheter related infection, clostridium difficile colitis, staphylococcal infection. ERLOTINIB dosage: (200 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, KEPPRA, MINOCYCLINE, FLAGYL, PROTONIX, LOTREL, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5567677-9
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Nov 30, 2007. Male patient, 80 years of age, was diagnosed with lung neoplasm malignant and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: anaemia, asthenia, fatigue, nausea. ERLOTINIB dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5568029-8
Physician from UNITED STATES reported ERLOTINIB problem on Dec 03, 2007. Male patient, 76 years of age, weighting 178.6 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: ileus, small intestinal obstruction. ERLOTINIB dosage: 150 MG, QD) ORAL. During the same period patient was treated with BEVACIZUMAB, TOPROL, LIPITOR, NIASPAN, NITROSTAT, ASPIRIN, ALLEGRA, LOPERAMIDE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5572354-4
ERLOTINIB problem was reported by a Physician from ITALY on Dec 04, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage. ERLOTINIB dosage: (150 MG,QD), ORAL. During the same period patient was treated with KETOROLAC. Patient died.
Erlotinib Side Effects Report #5572355-6
Physician from ISRAEL reported ERLOTINIB problem on Dec 04, 2007. Male patient, 83 years of age, was diagnosed with non-small cell lung cancer stage iv and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, dyspnoea, pleural effusion, protein total decreased. ERLOTINIB dosage: (50 MG, QD), ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5573226-1
ERLOTINIB problem was reported by a Physician from JAPAN on Dec 05, 2007. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: abdominal pain lower, anorexia, blood glucose increased, body temperature increased, cardiomegaly, central nervous system neoplasm, cholangitis, constipation, diarrhoea. ERLOTINIB dosage: 100 MG (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, DEXAMETHASONE PHOSPHATE, OXYCODONE, SULINDAC, TEPRENONE, RABEPRAZOLE, FUROSEMIDE, AMLODIPINE BESYLATE. Patient recovered.
Erlotinib Side Effects Report #5573247-9
Physician from KOREA, REPUBLIC OF reported ERLOTINIB problem on Dec 06, 2007. Male patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: pneumothorax. ERLOTINIB dosage: (150 MG, QD), ORAL. During the same period patient was treated with DIHYDROCODEINE TARTRATE, DOXOFYLLINE, MONTELUKAST. Patient died on 05/10/2007.
Erlotinib Side Effects Report #5578125-7
ERLOTINIB problem was reported by a Physician from NETHERLANDS on Dec 18, 2007. Female patient, 40 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: anaemia, anxiety, haemoptysis, respiratory arrest. ERLOTINIB dosage: (150 MG, QD), ORAL. During the same period patient was treated with INDOMETHACIN, CLARITHROMYCIN, AUGMENTIN, DOPAMINE, ACTRAPID, MIDAZOLAM, HALOPERIDOL, MINRIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5578137-3
Health Professional from KOREA, REPUBLIC OF reported ERLOTINIB problem on Dec 17, 2007. Male patient, 66 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, blood calcium decreased, blood glucose increased, blood phosphorus decreased, blood sodium decreased, carbon dioxide decreased, interstitial lung disease, lymphocyte percentage decreased, malignant neoplasm progression. ERLOTINIB dosage: (150 MG, QD), ORAL. During the same period patient was treated with RIFAMPICIN, ETHAMBUTOL. Patient died on 07/17/2007.
Erlotinib Side Effects Report #5578138-5
ERLOTINIB problem was reported by a Physician from FRANCE on Dec 17, 2007. Female patient, 77 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: abscess, colitis. ERLOTINIB dosage: (150 MG, QD), ORAL. During the same period patient was treated with PROPRANOLOL, AMLODIPINE BESYLATE, DI ANTALVIC, FENOFIBRATE, LEXOMIL, ZOLPIDEM TARTRATE, DIASEPTYL, SPASFON. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5578147-6
Physician from KOREA, REPUBLIC OF reported ERLOTINIB problem on Dec 18, 2007. Female patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased, prothrombin time prolonged, pulmonary embolism. ERLOTINIB dosage: (150 MG,QD), ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5578153-1
ERLOTINIB problem was reported by a Health Professional from JAPAN on Dec 18, 2007. Male patient, 69 years of age, was diagnosed with pancreatic carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: abdominal distension, arterial rupture, blood albumin decreased, blood creatinine increased, blood glucose increased, blood lactate dehydrogenase increased, blood potassium increased, blood urea increased, c-reactive protein increased. ERLOTINIB dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, GRANISETRON HYDROCHLORIDE, DEXAMETHASONE PHOSPHATE, VALSARTAN, ASPIRIN, PIRENOXINE, LOXOPROFEN, REBAMIPIDE. Patient died.
Erlotinib Side Effects Report #5578158-0
Physician from GERMANY reported ERLOTINIB problem on Dec 18, 2007. Male patient, 75 years of age, was diagnosed with bronchial carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: pneumothorax, soft tissue disorder. ERLOTINIB dosage: (100 MG, QD), ORAL. During the same period patient was treated with MORPHINE, PREDNISONE, NOVAMINSULFON, ZOMETA, DICODID, FORADIL, SPIRIVA. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5578159-2
ERLOTINIB problem was reported by a Physician from SWITZERLAND on Dec 14, 2007. Male patient, 61 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: pneumomediastinum. ERLOTINIB dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5578433-X
Physician from UNITED STATES reported ERLOTINIB problem on Dec 10, 2007. Female patient, 79 years of age, weighting 101.0 lb, was diagnosed with metastatic neoplasm, neoplasm malignant and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: asthenia, blood sodium decreased, blood urea increased, blood urea nitrogen/creatinine ratio increased, breath sounds abnormal, constipation, dehydration, diarrhoea, dysphagia. ERLOTINIB dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5578434-1
ERLOTINIB problem was reported by a Physician from UNITED STATES on Dec 12, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: dehydration, hypoxia, pneumocystis jiroveci pneumonia, pulmonary fibrosis, pyrexia. ERLOTINIB dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5506355-9
Physician from GERMANY reported ERLOTINIB problem on Oct 18, 2007. Female patient, 65 years of age, was diagnosed with lung neoplasm malignant and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: diarrhoea. ERLOTINIB dosage: 150 MG, QD, ORAL. During the same period patient was treated with SYMBICORT, HYOSCINE HYT. Patient died on 11/28/2006.
Erlotinib Side Effects Report #5506948-9
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Oct 19, 2007. Female patient, 48 years of age, weighting 102.1 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: electromechanical dissociation, mouth haemorrhage, pulmonary haemorrhage, thrombosis. ERLOTINIB dosage: 150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient died on 09/28/2007.
Erlotinib Side Effects Report #5506949-0
Health Professional from UNITED STATES reported ERLOTINIB problem on Oct 18, 2007. Male patient, 52 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: anaemia, blood albumin decreased, blood alkaline phosphatase increased, condition aggravated, dehydration, diarrhoea, lung cancer metastatic, pneumonia. ERLOTINIB dosage: 150 MG, QD, ORAL. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5509040-2
ERLOTINIB problem was reported by a Physician from DENMARK on Oct 23, 2007. Male patient, 71 years of age, was diagnosed with gastrointestinal carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: hypertension. ERLOTINIB dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, PAMOL, MORPHINE, PREDINISOLONE, DULCOLAX, PANTOPRAZOLE, PERINDOPRIL ERBUMINE, CENTYL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5509047-5
Physician from DENMARK reported ERLOTINIB problem on Oct 19, 2007. Male patient, 67 years of age, was diagnosed with gastrointestinal carcinoma, gastric cancer, pain, nausea, weight control and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: blood albumin decreased, blood alkaline phosphatase increased, diarrhoea, feeling abnormal, haemoglobin decreased, skin disorder. ERLOTINIB dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, FENTANYL, ACETAMINOPHEN, MORPHINE, IMODIUM, PREDNISONE, SUPPLEMENT NOS, GABAPENTIN. Patient died on 09/10/2007.
Erlotinib Side Effects Report #5510791-4
ERLOTINIB problem was reported by a Physician from UNITED STATES on Oct 27, 2007. Male patient, weighting 6.61 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: hand deformity. ERLOTINIB dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient recovered.
Erlotinib Side Effects Report #5510792-6
Health Professional from UNITED STATES reported ERLOTINIB problem on Oct 23, 2007. Male patient, weighting 84.00 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased, rectal haemorrhage. ERLOTINIB dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5515252-4
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Nov 13, 2007. Male patient, weighting 189.6 lb, was diagnosed with colorectal cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: abdominal pain, chest pain, enterovesical fistula. ERLOTINIB dosage: 75 MG, QD. During the same period patient was treated with BEVACIZUMAB, EVEROLIMUS, DITROPAN, PRILOSEC, NORVASC, AUGMENTIN, DEXAMETHASONE, DIOVAN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5515867-3
Physician from DENMARK reported ERLOTINIB problem on Oct 25, 2007. Female patient, 55 years of age, was diagnosed with gastrointestinal carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: catheter related complication, dyspnoea, haemoglobin decreased, infection, thrombocytopenia. ERLOTINIB dosage: (150 MG), ORAL. During the same period patient was treated with BEVACIZUMAB, TENORMIN, ACETAMINOPHEN, WHOLE BLOOD. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5517708-7
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Oct 29, 2007. Male patient, 93 years of age, weighting 117.1 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: anorexia, chest pain, dehydration, haemoglobin decreased, weight decreased. ERLOTINIB dosage: 125 MG, QD, ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5517710-5
Physician from UNITED STATES reported ERLOTINIB problem on Oct 26, 2007. Female patient, 72 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood sodium decreased, dehydration, disease progression, lymphocyte count decreased, thrombocytopenia. ERLOTINIB dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, COLACE, COMPAZINE, DILAUDID, FLUCONAZOLE, GLYBURIDE, MIRALAX. Patient recovered.
Erlotinib Side Effects Report #5517711-7
ERLOTINIB problem was reported by a Physician from UNITED STATES on Oct 26, 2007. Female patient, weighting 157.9 lb, was diagnosed with lung neoplasm malignant and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: hospitalisation. ERLOTINIB dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB. Patient died.
Erlotinib Side Effects Report #5517712-9
Physician from UNITED STATES reported ERLOTINIB problem on Oct 26, 2007. Male patient, 78 years of age, was diagnosed with hepatic neoplasm malignant non-resectable and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, hypertension, proteinuria. ERLOTINIB dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, LISINOPRIL, LOSARTAN POTASSIUM, NADOLOL, NEXIUM. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5518470-4
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Nov 13, 2007. Female patient, 78 years of age, weighting 184.0 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, diarrhoea, headache, nausea. ERLOTINIB dosage: 150 MG DAILY 047. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5518828-3
Health Professional from UNITED STATES reported ERLOTINIB problem on Nov 13, 2007. Male patient, weighting 134.5 lb, was diagnosed with thymoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: dermatitis acneiform, mucosal inflammation, perirectal abscess. ERLOTINIB dosage: 75 MG, QD. During the same period patient was treated with BEVACIZUMAB, EVEROLIMUS, BIOFLAVONOIDS, SPIRULINA, COUMADIN, PROTONIX, TYLENOL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5523651-X
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Nov 16, 2007. Male patient, weighting 167.0 lb, was diagnosed with non-small cell lung cancer, pain, erectile dysfunction, medical diet and was treated with ERLOTINIB. ERLOTINIB dosage: 150 MG, QD. During the same period patient was treated with BEVACIZUMAB, FENTANYL TRANSDERMAL SYSTEM, VICODIN, CIALIS, TYLENOL, GLUCOSAMINE, VITAMIN D. Patient died on 10/01/2007.
Erlotinib Side Effects Report #5525738-4
Physician from UNITED STATES reported ERLOTINIB problem on Nov 07, 2007. Male patient, weighting 6.61 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: congenital hand malformation, limb reduction defect. ERLOTINIB dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient recovered.
Erlotinib Side Effects Report #5526191-7
ERLOTINIB problem was reported by a Physician from SWEDEN on Nov 06, 2007. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: diarrhoea, lung neoplasm malignant, malignant neoplasm progression, malnutrition, metastases to bone, nausea, pain, vomiting. ERLOTINIB dosage: 150 MG (150 MG,QD), ORAL. During the same period patient was treated with OXYCONTIN, PREDNISONE, ACETAMINOPHEN, COZAAR, METOPROLOL TARTRATE, ENOXAPARIN, IMOVANE, OXYCODONE. Patient was hospitalized. Patient died on 01/18/2007.
Erlotinib Side Effects Report #5526192-9
Physician from CANADA reported ERLOTINIB problem on Nov 05, 2007. Male patient, 51 years of age, weighting 138.2 lb, was diagnosed with pancreatic carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: abscess, anuria, atelectasis, dilatation intrahepatic duct acquired, intestinal perforation, metastases to liver, pelvic pain, peritonitis, pleural effusion. ERLOTINIB dosage: (150 MG, QD), ORAL. During the same period patient was treated with OXYCONTIN, OXYCODONE, CREON, SENOKOT, COLACE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5527191-3
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on Nov 05, 2007. Male patient, weighting 84.00 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, deep vein thrombosis, international normalised ratio increased, prothrombin time prolonged, rectal haemorrhage. ERLOTINIB dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, WARFARIN, ENOXAPARIN, ALPRAZOLAM, OXYCODONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5527205-0
Physician from UNITED STATES reported ERLOTINIB problem on Nov 07, 2007. Female patient, 79 years of age, weighting 113.0 lb, was diagnosed with neoplasm malignant and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: asthenia, ataxia, atelectasis, blood chloride increased,